文献速递角膜与眼表疾病

微孢子虫性角膜基质炎的角膜组织病理学评估

Histopathological Evaluation of Corneal Tissues in Microsporidia Stromal Keratitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

该回顾性非比较连续病例系列纳入2015年6月至2023年4月间组织学诊断的22例微孢子虫性角膜基质炎(MSK)患者的22枚角膜植片,评估临床、微生物学、治疗及组织病理学特征。涂片检出微孢子虫孢子者占59%,41%病例微生物学检查未见病原体;13例接受0.02%聚六亚甲基双胍(PHMB)靶向治疗,9例经验性治疗。组织病理学显示炎症细胞分布与微孢子虫分布无显著相关性,中等微孢子虫严重程度与更长的症状持续时间(10.0±6.36个月)相关。

要点

  • 22例MSK角膜植片中涂片检出微孢子虫孢子者占59%,41%病例微生物学检查未见病原体。
  • 13例接受0.02% PHMB靶向治疗,9例接受经验性治疗。
  • 组织病理学显示炎症细胞分布与微孢子虫分布无显著相关性。

核心结论

  • 晚期MSK的进展似乎受病原体相关因素(如高微孢子虫负荷伴深部基质穿透)和宿主相关因素(如显著的炎症反应)共同影响。
  • 局部PHMB的有效性有限可能促进疾病进展。

研究设计与样本

  • 回顾性非比较连续病例系列,纳入2015年6月至2023年4月组织学诊断的MSK角膜植片22枚(22例患者)。
  • 评估术前临床和微生物学资料以及术后角膜植片的微生物学和组织病理学资料。

主要发现

  • 患者平均年龄57.1±13.4岁(范围22-83岁)。
  • 从症状出现到就诊的中位间隔为4个月,从就诊到角膜移植的平均时间为1个月。
  • 涂片检出微孢子虫孢子者占59%,41%病例微生物学检查未见病原体。
  • 13例接受0.02% PHMB靶向治疗,9例接受经验性治疗。
  • 组织病理学显示炎症细胞分布与微孢子虫分布无显著相关性;中等微孢子虫严重程度与更长症状持续时间(10.0±6.36个月)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the histopathological factors in non-resolving cases of microsporidia stromal keratitis (MSK) through the study of corneal buttons obtained during therapeutic penetrating keratoplasty (TPK). METHODS: This was a retrospective noncomparative consecutive case series. This case series included 22 corneal buttons (22 patients) of histologically diagnosed MSK between June 2015 and April 2023. Records of preoperative clinical and microbiological data, and postoperative microbiological and histopathologic data of the corneal buttons were evaluated. RESULTS: Histologic evaluation was conducted of the buttons for morphologic changes, degree and distribution of inflammatory cells, presence of microsporidial spores, and their degree and distribution within the corneal buttons. This study evaluated 22 patients with MSK, highlighting clinical, microbiological, treatment, and histopathological findings. The mean patient age was 57.1 ± 13.4 years (range = 22-83 years). The median interval from symptom onset to presentation was 4 months, and the mean time from presentation to keratoplasty was 1 month. Microsporidia spores were detected in 59% of cases through smears, with 41% of cases showing no organisms on microbiological tests. Targeted therapy using polyhexamethylene biguanide (PHMB) 0.02% was given in 13 cases, whereas 9 cases were treated empirically. Histopathology showed no significant correlation between the distribution of inflammatory cells and that of microsporidia. Moderate microsporidia severity correlated with longer symptom duration (10.0 ± 6.36 months). These findings underscore the complexity of MSK management and the variable outcomes. CONCLUSIONS: The progression of MSK in advanced stages appears to be influenced by a combination of pathogen-related factors, such as high microsporidial load with deep stromal penetration, and host-related factors, including a pronounced inflammatory response. Additionally, the limited effectiveness of topical PHMB may contribute to disease progression.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Mandal S, Sucharita S, Deshmukh V, et al. Histopathological Evaluation of Corneal Tissues in Microsporidia Stromal Keratitis. Invest Ophthalmol Vis Sci. 2025. PMID: 40178481. doi:10.1167/iovs.66.4.9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。